Clinical Trial Update: ProGRP, CgA, NSE and TUM2-PK in in Patients With Neuroendocrine Tumors

View source ↗

Summary

This clinical trial update investigates biomarkers ProGRP, CgA, NSE, and TUM2-PK in patients with neuroendocrine tumors. The current status of the study is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Neuroendocrine Tumors | Status: UNKNOWN